About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

FDA Recommends Strong Warning Labels On the ADHD Drugs

by Medindia Content Team on March 18, 2006 at 2:14 PM
Font : A-A+

FDA Recommends Strong Warning Labels On the ADHD Drugs

Shire Pharmaceuticals' top-selling Adderall XR drug for attention deficit hyperactivity disorder (ADHD) needs to carry stronger warnings about the risk of side effects says the US FDA regulators.

It has asked the drug company to make clear to the public about the side effects of the drug such as hallucinations and paranoia.

Advertisement

This can occur in some patients with no identifiable risk factors. The FDA had prepared a report about a seven-year-old boy who, after taking ADHD drugs imagined seeing people sitting in a rocking chair and people coming into the house and stealing Christmas presents. Another such incident is that of a five-year-old boy who said he saw snakes and polka-dot alligators.

The spokesman for Shire said that it was too early to speculate on the outcome of next week's meeting. He said that any type of enhanced warning should be based on scientific data. But there is not enough data at the moment to warrant enhanced warnings.
Advertisement

The FDA's Drug Safety and Risk Management Advisory Committee talked about the heart risks due to the usage of ADHD drugs. The FDA advisory panel said that the ADHD drugs namely the Shire's Adderall and Novartis's Ritalin, should carry black box warnings highlighting the risk of heart attacks.

Thomas Laughren, director of the Division of Pyschiatry Products at the FDA, said that as of now nothing has to be changed and the labeling right now is adequate.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Can Weight Loss be Achieved by Drinking Water?
Can Exercise Counts Boost Your Life Counts? 
Prevent Hacking of Medical Devices: FDA Sounds Alarm
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Dyslexia Attention Deficit Hyperactivity Disorder (ADHD) Signature Drug Toxicity Bullying at School - Tips For Schools ADHD Dyscalculia / Learning Disabilities Diet to control Attention Deficit Hyperactivity Disorder Mind-wandering Adult Attention-Deficit Hyperactivity Disorder (ADHD) 

Most Popular on Medindia

Find a Doctor A-Z Drug Brands in India Indian Medical Journals Sanatogen Sinopril (2mg) (Lacidipine) Color Blindness Calculator Drug - Food Interactions Drug Interaction Checker Find a Hospital Daily Calorie Requirements

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE